This site is intended for Healthcare Professionals only.

Tag: breast cancer

spot_imgspot_img

Drugs to Watch 2024: Here are 13 potential blockbuster therapies expected to launch this year

In addition, Clarivate report highlights some new technology platforms that are likely to achieve significant proof of medical use in the market in 2024  Information...

‘Repurposed’ NHS drug could help prevent thousands of women from breast cancer

The drug can 'reduce' breast cancer incidence in post-menopausal women by almost 50 per cent The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved Anastrozole...

NICE recommends Enhertu for advanced breast cancer

The National Institute for Health and Care Excellence (NICE) has recommended Enhertu for people with advance breast cancer. “There is not enough evidence yet to...

NHS introduces ‘Pembrolizumab’ to treat triple-negative breast cancer

The NHS has secured a deal for ‘Pembrolizumab’ to treat women with triple-negative breast cancer. Up to 1,600 women a year affected by high risk...

NICE recommends abemaciclib for early breast cancer

The National Institute for Health and Care Excellence (NICE) has recommended abemaciclib also called Verzenios, made by Eli Lilly, for people with hormone receptor-positive,...

NICE recommends new injectable immunotherapy treatment for rare triple negative breast cancer

The National Institute for Health and Care Excellence (NICE) has recommended pembrolizumab in combination with chemotherapy (paclitaxel or nab-paclitaxel) (Injectable immunotherapy treatment) which is...